Kim I S, Seong S Y, Woo S G, Choi M S, Kang J S, Chang W H
Department of Microbiology, Seoul National University College of Medicine, Republic of Korea.
J Clin Microbiol. 1993 Aug;31(8):2057-60. doi: 10.1128/jcm.31.8.2057-2060.1993.
The genes encoding the 56-kDa polypeptides were amplified by polymerase chain reaction from the genomic DNAs of three serotypes of Rickettsia tsutsugamushi, Gilliam, Karp, and Boryong. The amplified products were cloned into expression vector pIH821, and the recombinant antigens were expressed in Escherichia coli as fusion proteins with maltose-binding protein. The recombinant 56-kDa polypeptides were purified by affinity chromatography for the sensitization of sheep erythrocytes. The recombinant 56-kDa polypeptides were evaluated with 89 serum specimens from health blood donors, 94 serum specimens from scrub typhus patients, and 31 serum specimens from patients with other febrile diseases by a passive hemagglutination assay (PHA). Among the scrub typhus patients diagnosed by indirect immunofluorescent-antibody testing, the antibodies to R. tsutsugamushi were detected in 93 patients (99%). One serum specimen from a healthy person showed a false-positive reaction by this method. The recombinant PHA showed no cross-reactions with sera obtained from other febrile patients with diseases such as murine typhus, hemorrhagic fever with renal syndrome, and leptospirosis. In conclusion, this recombinant PHA could be substituted for the conventional indirect immunofluorescent-antibody test and the immunoperoxidase test.
通过聚合酶链反应从恙虫病东方体的3个血清型(Gilliam、Karp和Boryong)的基因组DNA中扩增出编码56-kDa多肽的基因。将扩增产物克隆到表达载体pIH821中,重组抗原在大肠杆菌中作为与麦芽糖结合蛋白的融合蛋白表达。通过亲和层析纯化重组56-kDa多肽以致敏绵羊红细胞。通过被动血凝试验(PHA)对89份健康献血者血清标本、94份恙虫病患者血清标本和31份其他发热性疾病患者血清标本进行重组56-kDa多肽评估。在通过间接免疫荧光抗体检测诊断的恙虫病患者中,93例(99%)检测到抗恙虫病东方体抗体。1份健康人血清标本通过该方法出现假阳性反应。重组PHA与来自其他发热性疾病患者(如鼠型斑疹伤寒、肾综合征出血热和钩端螺旋体病)的血清无交叉反应。总之,这种重组PHA可替代传统的间接免疫荧光抗体试验和免疫过氧化物酶试验。